Belzutifan is a kind of medicine that blocks the HIF-2α protein, which is used to treat RCC linked to VHL. It helps cut down the low-oxygen signals in tumors. It’s available as 40 mg tablets with a coating.
The regular amount you take is 120 mg, and you should take it just once every day. You’ll find it in bottles that hold 90 of these tablets.
